EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B

Carolyn Nicole Brown, Rachel E Blaine, Chase Madison Barker, Steven J Coultrap, Karl Ulrich Bayer

Molecular Pharmacology · 2025

DOI: 10.1016/j.molpha.2025.100029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Carolyn Nicole Brown und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Neuroprotective Agents, Cyclopentanes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIH National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateCalcium-Calmodulin-Dependent Protein Kinase Type 2Neuroprotective AgentsCyclopentanesHumansHEK293 CellsAnimalsPhosphorylationLong-Term PotentiationHippocampusNeuronsProtein BindingRats

Stichwörter der Autor:innen

CaMKIICerebral ischemiaGluN2BLTPSynapse

Substanzen

Receptors, N-Methyl-D-AspartateCalcium-Calmodulin-Dependent Protein Kinase Type 2NR2B NMDA receptorNeuroprotective AgentsCyclopentanes

Autor:innen und Institutionen

  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: ulli.bayer@cuanschutz.edu.

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • NIH National Institute of General Medical Sciences
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging

Zitieren

APA

Brown, C. N., Blaine, R. E., Barker, C. M., Coultrap, S. J., & Bayer, K. U. (2025). The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100029

Vancouver

Brown CN, Blaine RE, Barker CM, Coultrap SJ, Bayer KU. The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100029

BibTeX
@article{Brown2025,
  author = {Brown, Carolyn Nicole and Blaine, Rachel E and Barker, Chase Madison and Coultrap, Steven J and Bayer, Karl Ulrich},
  title = {The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B},
  journal = {Molecular Pharmacology},
  year = {2025},
  doi = {10.1016/j.molpha.2025.100029}
}
Kostenlos starten →